| Attribute |
Value |
| 52 Week Change |
-0.9519546 |
| Address1 |
2,929 North Commerce Parkway |
| All Time High |
311.0 |
| All Time Low |
0.25 |
| Ask |
0.4966 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
566,020 |
| Average Daily Volume3 Month |
8,403,354 |
| Average Volume |
8,403,354 |
| Average Volume10Days |
566,020 |
| Beta |
0.905 |
| Bid |
0.2877 |
| Bid Size |
2 |
| Book Value |
0.843 |
| City |
Miramar |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
0.381 |
| Current Ratio |
0.108 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,774,915,200 |
| Day High |
0.4196 |
| Day Low |
0.3741 |
| Debt To Equity |
246.285 |
| Display Name |
HCW Biologics |
| Ebitda |
-12,620,739 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-0.588 |
| Enterprise To Revenue |
136.865 |
| Enterprise Value |
7,422,444 |
| Eps Forward |
-0.55 |
| Eps Trailing Twelve Months |
-9.54 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fax |
954 842 2037 |
| Fifty Day Average |
0.5502 |
| Fifty Day Average Change |
-0.16919997 |
| Fifty Day Average Change Percent |
-0.3075245 |
| Fifty Two Week Change Percent |
-95.19546 |
| Fifty Two Week High |
17.8 |
| Fifty Two Week High Change |
-17.418999 |
| Fifty Two Week High Change Percent |
-0.9785955 |
| Fifty Two Week Low |
0.25 |
| Fifty Two Week Low Change |
0.13100001 |
| Fifty Two Week Low Change Percent |
0.52400005 |
| Fifty Two Week Range |
0.25 - 17.8 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,626,787,800,000 |
| Float Shares |
6,100,492 |
| Forward Eps |
-0.55 |
| Forward P E |
-0.69272727 |
| Free Cashflow |
-15,625,519 |
| Full Exchange Name |
NasdaqCM |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
0.19999 |
| Gross Profits |
10,846 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.08604 |
| Held Percent Institutions |
0.06782 |
| Implied Shares Outstanding |
6,734,104 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ipo Expected Date |
2,021-07-20 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,744,329,600 |
| Last Split Factor |
1:40 |
| Long Business Summary |
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201 and HCW9206, novel immunotherapeutic for memory-like natural killer cells, cancer, and pathogens; HCW11-006, an immune cell stimulator; HCW11-002 and HCW11-0027, which are immune checkpoint inhibitors to treat oncology and other senescence-associated indications; and HCW11-018, a fusions and immune cell engagers to treat cancer. The company has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida. |
| Long Name |
HCW Biologics Inc. |
| Market |
us_market |
| Market Cap |
2,565,693 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_628452149 |
| Most Recent Quarter |
1,767,139,200 |
| Net Income To Common |
-22,298,702 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
2,519,228 |
| Number Of Analyst Opinions |
1 |
| Open |
0.4 |
| Operating Cashflow |
-13,391,617 |
| Operating Margins |
-183.70314 |
| Payout Ratio |
0.0 |
| Phone |
954 842 2024 |
| Pre Market Change |
0.027999997 |
| Pre Market Change Percent |
7.3490806 |
| Pre Market Price |
0.409 |
| Pre Market Time |
1,776,849,580 |
| Previous Close |
0.411 |
| Price Hint |
4 |
| Price To Book |
0.45195732 |
| Price To Sales Trailing12 Months |
47.309578 |
| Profit Margins |
0.0 |
| Quick Ratio |
0.094 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.03 |
| Regular Market Change Percent |
-7.29927 |
| Regular Market Day High |
0.4196 |
| Regular Market Day Low |
0.3741 |
| Regular Market Day Range |
0.3741 - 0.4196 |
| Regular Market Open |
0.4 |
| Regular Market Previous Close |
0.411 |
| Regular Market Price |
0.381 |
| Regular Market Time |
1,776,801,601 |
| Regular Market Volume |
303,593 |
| Return On Assets |
-0.31189 |
| Revenue Growth |
-0.932 |
| Revenue Per Share |
0.026 |
| Sand P52 Week Change |
0.3140242 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
6,734,104 |
| Shares Percent Shares Out |
0.0164 |
| Shares Short |
110,641 |
| Shares Short Previous Month Date |
1,772,150,400 |
| Shares Short Prior Month |
57,608 |
| Short Name |
HCW Biologics Inc. |
| Short Percent Of Float |
0.0176 |
| Short Ratio |
0.0 |
| Source Interval |
15 |
| State |
FL |
| Symbol |
HCWB |
| Target High Price |
2.0 |
| Target Low Price |
2.0 |
| Target Mean Price |
2.0 |
| Target Median Price |
2.0 |
| Total Cash |
1,952,464 |
| Total Cash Per Share |
0.29 |
| Total Debt |
6,809,215 |
| Total Revenue |
54,232 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-9.54 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.527035 |
| Two Hundred Day Average Change |
-2.146035 |
| Two Hundred Day Average Change Percent |
-0.8492304 |
| Type Disp |
Equity |
| Volume |
303,593 |
| Website |
https://www.hcwbiologics.com |
| Zip |
33,025 |